Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOSUN PHARMA

13.980
+0.1601.16%
Volume:2.29M
Turnover:31.90M
Market Cap:37.23B
PE:12.67
High:14.060
Open:13.820
Low:13.800
Close:13.820
Loading ...

Shanghai Fosun Pharmaceutical to Sell 55% Stake in Investment Firm

MT Newswires Live
·
14 Apr

Fosun Pharmaceutical Unit Gets China Nod for Schizophrenia Drug Trial

MT Newswires Live
·
08 Apr

Shanghai Fosun Pharmaceutical Raises Stake in United Health Insurance; Shares Rise

MT Newswires Live
·
01 Apr

Fosun Pharmaceutical-Owned Gland Pharma to Invest 1.6 Billion Yuan in Indian Mutual Funds, Bonds

MT Newswires Live
·
26 Mar

China's NAFMII Accepts Fosun Pharma's Application to Issue Up to 10 Billion Yuan Bonds

MT Newswires Live
·
26 Mar

Press Release: Fosun Pharma Announces 2024 Annual Results

Dow Jones
·
26 Mar

Shanghai Fosun Pharmaceutical (Group)'s Subsidiary PNH Drug Gets NMPA's Nod for Clinical Trials; Shares Rise 4%

MT Newswires Live
·
14 Mar

Fosun Pharma Gets Clinical Trial Approval for Blood Disorder Drug

MT Newswires Live
·
14 Mar

Fosun Pharma Unit Gets China Nod to Register Foritinib Succinate Capsules

MT Newswires Live
·
07 Mar

Chinese Regulator Approves Shanghai Fosun Pharmaceutical's Vaccine for Clinical Trials

MT Newswires Live
·
04 Mar

Fosun Pharmaceutical Secures Clinical Trial Approval for Colorectal Cancer Treatment

MT Newswires Live
·
28 Feb

Fosun Pharmaceutical Gets Marketing Authorization for Chronic Kidney Disease Drug

MT Newswires Live
·
27 Feb

Fosun Pharmaceutical Unit Gets Chinese Regulator's Nod for Chronic Kidney Disease Tablets

MT Newswires Live
·
26 Feb

Fosun Pharmaceutical Unit Gets China Nod for Lung Diseases Drug

MT Newswires Live
·
26 Feb

Fosun Pharmaceutical Unit Gets China Nod for Colon Cleansing Granules

MT Newswires Live
·
26 Feb

BRIEF-Shanghai Fosun Pharma's Unit Received Marketing Registration Approval From NMPA China For Compound Sodium Picosulfate Granules

Reuters
·
26 Feb

BRIEF-Anhui Sunhere Says Shareholder Shanghai Fosun Pharma To Unload Up To 3% Stake

Reuters
·
23 Feb

Anhui Sunhere Says Shareholder Shanghai Fosun Pharmaceutical Plans to Unload up to 3% Stake in Three Months

THOMSON REUTERS
·
23 Feb

Fosun Pharma Unit to Boost Stake in Medical Services Firm with Additional Investment

MT Newswires Live
·
21 Feb

Fosun Pharmaceutical Gets US FDA Approval for HLX99 Clinical Trials

MT Newswires Live
·
11 Feb